Ascendis Pharma demonstrates its commitment to rare endocrine diseases at the…
COPENHAGEN, Denmark, May 13, 2023 (GLOBE NEWSWIRE) – Ascendis Pharma A/S ASND announced today that the Company will present clinical and research findings on hypoparathyroidism